(Q86876921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

6

Toru Sugiyama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

4

Tadahiro Shoji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

8

Junzo Kigawa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1

Hiroaki Itamochi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3

Tetsuro Oishi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

9

Tasuku Harada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Nao Oumi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hiroyuki Fujiwara

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Mitsuaki Suzuki

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

6 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

967-973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10147-015-0811-x

2 March 2020

exact match

0 references

cites work

The Chromatin Remodeling Gene ARID1A Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma

1 reference

12 December 2020

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

1 reference

12 December 2020

SWI/SNF nucleosome remodellers and cancer.

1 reference

12 December 2020

Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma

1 reference

12 December 2020

Chromatin remodelling during development

1 reference

12 December 2020

A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation

1 reference

12 December 2020

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles

1 reference

12 December 2020

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

12 December 2020

Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma

1 reference

12 December 2020

Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers

1 reference

12 December 2020

Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes

1 reference

12 December 2020

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma.

1 reference

12 December 2020

Genomic and functional evidence for an ARID1A tumor suppressor role

1 reference

12 December 2020

Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2.

1 reference

12 December 2020

Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer.

1 reference

12 December 2020

Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma

1 reference

12 December 2020

Ovarian atypical endometriosis: its close association with malignant epithelial tumours

1 reference

12 December 2020

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy.

1 reference

12 December 2020

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma

1 reference

12 December 2020

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.

1 reference

12 December 2020

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

1 reference

12 December 2020

Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma

1 reference

12 December 2020

Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer

1 reference

12 December 2020

ARID1A mutations in endometriosis-associated ovarian carcinomas

1 reference

12 December 2020

Does the Loss of ARID1A (BAF-250a) Expression in Endometrial Clear Cell Carcinomas Have Any Clinicopathologic Significance? A Pilot Assessment

1 reference

12 December 2020

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

1 reference

12 December 2020

Loss of ARID1A expression correlates with stages of tumor progression in uterine endometrioid carcinoma

1 reference

12 December 2020

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary

1 reference

12 December 2020

Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?

1 reference

12 December 2020

Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition

1 reference

12 December 2020

Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer.

1 reference

12 December 2020

Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

1 reference

12 December 2020

World Health Organization classification and nomenclature of ovarian cancer

1 reference

12 December 2020

Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer

1 reference

12 December 2020

Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription

1 reference

12 December 2020

10.1007/S10147-015-0811-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25744580%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference